Molecular Basis of pathogenicity in Helicobacter pylori clinical isolates
Ivy Bastos Ramis1, Tesiê Leopoldo Fonseca, Ernani Pinho de Moraes
1Laboratório de Biologia Molecular, Universidade Federal do Rio Grande, Rio Grande, RS, Brazil.
Journal of Clinical Microbiology
|August 6, 2010
Abstract:
This study identified pathogenicity genes in 40 Helicobacter pylori clinical isolates. The cagA, vacA, and iceA genes were detected in 65%, 97.5%, and 97.5% of the isolates, respectively. The cagA, iceA1, and vacAs1a/m1 genes were related to erosive gastritis, whereas the vacAs2/m2 and iceA2 genes were associated with enanthematous gastritis.
Insights
This study investigated Helicobacter pylori pathogenicity genes in clinical samples. Specific genes like cagA, vacA, and iceA were linked to different gastritis types, aiding in understanding H. pylori virulence.
Area of Science:
- Microbiology
- Genetics
- Gastroenterology
Background:
- Helicobacter pylori is a major cause of gastritis and peptic ulcers.
- Pathogenicity factors of H. pylori influence disease severity.
- Understanding gene-host interactions is crucial for managing H. pylori infections.
Purpose of the Study:
- To identify and characterize key pathogenicity genes in clinical isolates of Helicobacter pylori.
- To correlate the presence of specific H. pylori genes with distinct gastritis phenotypes.
Main Methods:
- Analysis of 40 clinical Helicobacter pylori isolates.
- Detection of cagA, vacA, and iceA gene families using molecular methods.
- Correlation of gene profiles with clinical diagnosis of erosive and enanthematous gastritis.
Main Results:
- High prevalence of vacA (97.5%) and iceA (97.5%) genes observed.
- cagA gene detected in 65% of isolates.
- Specific genotypes (cagA, iceA1, vacAs1a/m1) associated with erosive gastritis.
- Other genotypes (vacAs2/m2, iceA2) linked to enanthematous gastritis.
Conclusions:
- The study highlights the genotypic diversity of H. pylori clinical isolates.
- Specific H. pylori pathogenicity genes are significantly associated with gastritis types.
- Genotyping may offer insights into predicting H. pylori-associated gastric disease severity.
Related Concept Videos
01:26Gastritis II: Pathophysiology
The pathophysiology of gastritis begins with the colonization of the stomach lining by Helicobacter pylori (H. pylori). This bacterium spreads mainly via the oral-oral route through saliva or shared utensils, and can also be transmitted in overcrowded or unhygienic environments through contaminated water, despite its brief survival outside the body.ColonizationOnce ingested, H. pylori enters the stomach and begins colonization by navigating through the mucus layer lining the stomach wall. It...
01:20Determinants of Bacterial Pathogenicity and Virulence
Pathogenic bacteria employ a variety of strategies to establish infections, including the secretion of extracellular enzymes that act as potent virulence factors. These enzymes facilitate bacterial colonization of host tissues and help evade immune surveillance. By targeting structural components of host tissues and interfering with immune mechanisms, these enzymes play a pivotal role in disease progression.Extracellular Enzymes Facilitating Tissue Invasion: Several bacterial pathogens secrete...
01:24Peptic Ulcer Disease II: Pathophysiology
Peptic ulcer disease develops when protective mechanisms of the gastrointestinal mucosa are overwhelmed by harmful factors, leading to localized erosions in the stomach or proximal duodenum. The main causes are Helicobacter pylori infection and chronic use of nonsteroidal anti-inflammatory drugs (NSAIDs).Helicobacter pylori–Induced InjuryBacterial Adaptation and Colonization:H. pylori is a spiral, Gram-negative bacterium adapted to the acidic stomach. and transmitted through oral-oral or...
01:28Peptic Ulcer Disease II: Pathophysiology
Peptic Ulcer Disease (PUD) is characterized by the development of ulcers in the stomach or duodenal mucosa. Its pathophysiology is complex, involving a balance between damaging and protective elements.
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
01:27Peptic Ulcer
Peptic ulcers are erosive lesions of the gastric or duodenal lining, most commonly caused by Helicobacter pylori infection. This Gram-negative, helical bacterium has adapted to survive the stomach’s acidic environment by producing urease, which converts urea into ammonia and carbon dioxide. The ammonia neutralizes gastric acid in the bacterium’s immediate environment, allowing colonization of the gastric mucosa. H. pylori attaches to mucus-secreting epithelial cells, penetrates the mucus...
01:22Pathophysiology of Peptic Ulcer Disease: Injurious Factors
Peptic ulcers are sores on the stomach's inner lining and the upper small intestine, which are the result of disruptions in the mucosal layer that houses parietal cells which produce gastric acid, and chief cells which secrete pepsinogen.
In the antrum region, G cells secrete the gastrin hormone that binds to gastrin-cholecystokinin-B (CCK2) receptors on parietal and enterochromaffin-like (ECL) cells in the fundic glands. Simultaneously, the vagus nerve releases acetylcholine, which binds to M3...
In the antrum region, G cells secrete the gastrin hormone that binds to gastrin-cholecystokinin-B (CCK2) receptors on parietal and enterochromaffin-like (ECL) cells in the fundic glands. Simultaneously, the vagus nerve releases acetylcholine, which binds to M3...